In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Auxeris Therapeutics Inc.

www.auxeris.com

Latest From Auxeris Therapeutics Inc.

Start-Up Previews (7/03)

A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile groups feature companies developing Drugs that Promote Bone Growth, Breast Biopsy Technologies and Cardiovascular Drugs. Plus these selected Start-Ups across Health Care: BioSeek Inc., CombinatoRx Inc. and Cyberkinetics Inc.

Auxeris Therapeutics Inc.

Auxeris Therapeutics is using the cytokine RANK and its ligand as a drug target to identify anabolic bone-growth compounds.

BioPharmaceutical

Drugs that Induce Bone Growth

Inspired by the commercializing of Lilly's osteoporosis drug, Forteo, start-ups are developing new classes of anabolic bone-forming agents around known and novel drug targets.

BioPharmaceutical

Selected Start-Ups (11/2002)

In Vivo briefly summarizes the technologies of these recently founded companies: Anacor Pharmaceuticals Inc., Auxeris Therapeutics Inc., Chimerix Inc., Ercole BioTech Inc., iThemba Pharmaceuticals (Pty) Ltd. and Trinity Biosystems Inc.

See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
UsernamePublicRestriction

Register